Contract terms
Will Humira WAC be below $60,000/year by Dec 31, 2026? · v1 (current)
Market metadata
Market
humira-wac-below-60000-2026
Market ID
694558225cd285b7ccf3fb3a
Rules version
v1
Rules published
Dec 19, 2025, 01:50 PM
Opens
Dec 19, 2025, 01:50 PM
Locks
Feb 12, 2026, 01:50 PM
Resolve-by
—
Measurement
WAC per year
Outcomes
This is a binary market with outcomes YES and NO. If the market is voided, stakes are refunded.
Resolution rules
Resolves YES if Humira (adalimumab) US WAC annualized price is < $60,000/year as of Dec 31, 2026. Primary source: sponsor WAC/list price publication or a clearly cited WAC source. Otherwise NO.
Resolution procedure
Probiful admins resolve markets using the criteria above. If multiple sources disagree, admins follow the source hierarchy described in the resolution rules (if present).
Lock time: Feb 12, 2026, 01:50 PM. For “by date” markets, the phrase “on or before” is interpreted as inclusive of the calendar date shown in the contract.
If the market cannot be fairly resolved (e.g., no authoritative sources), it may be voided and stakes refunded.
Sources referenced
—
Accessed: Mar 26, 2026. This page is a snapshot of rules version v1.